tiprankstipranks
Trending News
More News >
Takeda Pharmaceutical Co Ltd (TKPHF)
OTHER OTC:TKPHF
US Market

Takeda Pharmaceutical Co (TKPHF) Ratios

Compare
35 Followers

Takeda Pharmaceutical Co Ratios

TKPHF's free cash flow for Q3 2025 was ¥0.54. For the 2025 fiscal year, TKPHF's free cash flow was decreased by ¥ and operating cash flow was ¥0.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.19 1.01 1.11 0.97 1.21
Quick Ratio
0.65 0.52 0.58 0.57 0.81
Cash Ratio
0.25 0.09 0.09 0.21 0.40
Solvency Ratio
0.11 0.12 0.11 0.13 0.11
Operating Cash Flow Ratio
0.43 0.38 0.28 0.39 0.52
Short-Term Operating Cash Flow Coverage
1.92 1.57 1.48 2.88 5.51
Net Current Asset Value
¥ -4.65T¥ -4.79T¥ -5.28T¥ -5.21T¥ -4.90T
Leverage Ratios
Debt-to-Assets Ratio
0.31 0.36 0.36 0.31 0.33
Debt-to-Equity Ratio
0.64 0.73 0.75 0.69 0.76
Debt-to-Capital Ratio
0.39 0.42 0.43 0.41 0.43
Long-Term Debt-to-Capital Ratio
0.36 0.36 0.38 0.39 0.42
Financial Leverage Ratio
2.02 2.05 2.08 2.20 2.32
Debt Service Coverage Ratio
1.32 1.33 1.74 2.21 3.00
Interest Coverage Ratio
1.32 3.36 3.46 2.89 2.77
Debt to Market Cap
0.59 0.66 0.75 0.65 0.79
Interest Debt Per Share
3.30K 3.34K 3.59K 2.93K 2.89K
Net Debt to EBITDA
3.14 4.31 5.67 3.25 2.95
Profitability Margins
Gross Profit Margin
56.31%53.59%54.53%69.11%68.99%
EBIT Margin
12.79%7.99%4.69%12.22%11.91%
EBITDA Margin
29.97%24.61%21.76%29.41%33.15%
Operating Profit Margin
10.77%13.70%12.46%12.18%12.91%
Pretax Profit Margin
4.60%3.82%1.24%9.31%8.48%
Net Profit Margin
2.53%2.36%3.38%7.87%6.45%
Continuous Operations Profit Margin
2.54%2.36%3.38%8.09%6.88%
Net Income Per EBT
54.99%61.64%272.90%84.52%76.03%
EBT Per EBIT
42.72%27.90%9.93%76.47%65.66%
Return on Assets (ROA)
0.73%0.76%0.95%2.27%1.75%
Return on Equity (ROE)
1.58%1.56%1.98%4.99%4.05%
Return on Capital Employed (ROCE)
3.76%5.34%4.15%4.27%4.18%
Return on Invested Capital (ROIC)
1.98%3.14%10.97%3.49%3.11%
Return on Tangible Assets
1.84%2.04%2.66%6.47%4.65%
Earnings Yield
1.36%1.55%2.21%4.70%4.21%
Efficiency Ratios
Receivables Turnover
5.89 6.32 6.11 5.91 4.93
Payables Turnover
4.17 6.89 6.06 4.05 3.74
Inventory Turnover
1.39 1.75 1.60 1.26 1.30
Fixed Asset Turnover
2.14 2.33 2.14 2.38 2.25
Asset Turnover
0.29 0.32 0.28 0.29 0.27
Working Capital Turnover Ratio
6.94 35.22 52.80 22.13 5.14
Cash Conversion Cycle
237.79 213.80 227.25 260.99 257.84
Days of Sales Outstanding
61.96 57.78 59.72 61.78 74.08
Days of Inventory Outstanding
263.33 208.96 227.76 289.42 281.35
Days of Payables Outstanding
87.50 52.95 60.23 90.20 97.59
Operating Cycle
325.30 266.74 287.48 351.20 355.43
Cash Flow Ratios
Operating Cash Flow Per Share
710.55 609.61 409.29 629.69 718.33
Free Cash Flow Per Share
589.53 482.43 297.17 221.33 599.34
CapEx Per Share
121.02 127.18 112.13 408.36 118.99
Free Cash Flow to Operating Cash Flow
0.83 0.79 0.73 0.35 0.83
Dividend Paid and CapEx Coverage Ratio
2.23 1.91 1.38 1.07 2.39
Capital Expenditure Coverage Ratio
5.87 4.79 3.65 1.54 6.04
Operating Cash Flow Coverage Ratio
0.23 0.19 0.12 0.22 0.26
Operating Cash Flow to Sales Ratio
0.25 0.21 0.15 0.24 0.31
Free Cash Flow Yield
11.25%10.93%7.15%5.09%17.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
73.32 64.56 45.16 21.29 23.77
Price-to-Sales (P/S) Ratio
1.85 1.52 1.53 1.68 1.53
Price-to-Book (P/B) Ratio
1.08 1.00 0.89 1.06 0.96
Price-to-Free Cash Flow (P/FCF) Ratio
8.89 9.15 14.00 19.65 5.84
Price-to-Operating Cash Flow Ratio
7.38 7.24 10.16 6.91 4.87
Price-to-Earnings Growth (PEG) Ratio
0.31 -2.51 -0.82 0.55 -0.61
Price-to-Fair Value
1.08 1.00 0.89 1.06 0.96
Enterprise Value Multiple
9.33 10.49 12.68 8.95 7.58
Enterprise Value
12.48T 11.82T 11.76T 10.60T 8.96T
EV to EBITDA
9.33 10.49 12.68 8.95 7.58
EV to Sales
2.80 2.58 2.76 2.63 2.51
EV to Free Cash Flow
13.40 15.52 25.31 30.86 9.57
EV to Operating Cash Flow
11.12 12.28 18.37 10.85 7.98
Tangible Book Value Per Share
-1.03K -1.28K -1.54K -1.74K -1.63K
Shareholders’ Equity Per Share
4.84K 4.39K 4.65K 4.09K 3.63K
Tax and Other Ratios
Effective Tax Rate
0.45 0.38 -1.73 0.15 0.24
Revenue Per Share
2.83K 2.90K 2.73K 2.60K 2.28K
Net Income Per Share
71.49 68.36 92.09 204.29 147.14
Tax Burden
0.55 0.62 2.73 0.85 0.76
Interest Burden
0.36 0.48 0.26 0.76 0.71
Research & Development to Revenue
0.16 0.16 0.17 0.16 0.15
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 0.00 0.00 0.02 0.01
Income Quality
9.92 8.92 4.44 3.08 4.88
Currency in JPY